Literature DB >> 2610498

Effects of ciprofloxacin on testosterone and cortisol concentrations in healthy males.

N M Waite1, D J Edwards, W S Arnott, L H Warbasse.   

Abstract

Several inhibitors of oxidative drug metabolism inhibit the synthesis of endogenous compounds such as testosterone and cortisol. Since ciprofloxacin is a potent inhibitor of the metabolism of a number of drugs, we studied its effect on serum testosterone and cortisol concentrations in eight healthy male subjects. Blood samples were collected over a 12-h period under baseline conditions and following the first and final doses of ciprofloxacin (500 mg orally every 12 h for 4 days). No significant differences in concentrations or area under the concentration-time curve were found when baseline values were compared with those observed for either testosterone or cortisol after ciprofloxacin administration. These results suggest that ciprofloxacin is unlikely to have either antiandrogenic side effects or clinical utility in lowering testosterone or cortisol concentration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2610498      PMCID: PMC172780          DOI: 10.1128/AAC.33.11.1875

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Effects of single and multiple doses of ketoconazole on adrenal function in normal subjects.

Authors:  I D Bradbrook; H C Gillies; P J Morrison; J Robinson; H J Rogers; R G Spector
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

2.  Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy.

Authors:  F J Holland; L Fishman; J D Bailey; A T Fazekas
Journal:  N Engl J Med       Date:  1985-04-18       Impact factor: 91.245

3.  Inhibition by omeprazole of adrenocortical response to ACTH: clinical studies and experiments on bovine adrenal cortex in vitro.

Authors:  C W Howden; C J Kenyon; G H Beastall; J L Reid
Journal:  Clin Sci (Lond)       Date:  1986-01       Impact factor: 6.124

Review 4.  Inhibition of drug metabolism by quinolone antibiotics.

Authors:  D J Edwards; S K Bowles; C K Svensson; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

5.  Effect of ketoconazole on hepatic oxidative drug metabolism.

Authors:  M W Brown; A L Maldonado; C G Meredith; K V Speeg
Journal:  Clin Pharmacol Ther       Date:  1985-03       Impact factor: 6.875

6.  Ketoconazole blocks adrenal steroid synthesis.

Authors:  A Pont; P L Williams; D S Loose; D Feldman; R E Reitz; C Bochra; D A Stevens
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

7.  High-dose ketoconazole therapy and adrenal and testicular function in humans.

Authors:  A Pont; J R Graybill; P C Craven; J N Galgiani; W E Dismukes; R E Reitz; D A Stevens
Journal:  Arch Intern Med       Date:  1984-11

8.  Ketoconazole inhibits cyclosporine metabolism in vivo in mice.

Authors:  J E Anderson; T F Blaschke
Journal:  J Pharmacol Exp Ther       Date:  1986-03       Impact factor: 4.030

9.  Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.

Authors:  R Gugler; J C Jensen
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

10.  Effect of a single administration of ketoconazole on total and physiologically free plasma testosterone and 17 beta-oestradiol levels in healthy male volunteers.

Authors:  R De Coster; I Caers; C Haelterman; M Debroye
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.